| Application no. and date | 14710654.6 (espacenet) (Federated) (European Patent Register), 20140306 | | Patent/reg. no. and date | DK/EP 2964202, 20181031 | | Publication date | 20160113 | | Priority no. and date | US 201361774893 P, 20130308, US 201361824435 P, 20130517 | | EP pub. no. and date |
EP 2964202 20160113 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/158028 | | Inventor | GHOSH, Indrajit, c/o NOVARTIS PHARMACEUTICALS CORPORATION
One Health Plaza
East Hanover, New Jersey 07936-1080, US,
ZHANG, Jia-Ai, c/o NOVARTIS PHARMACEUTICALS CORPORATION
One Health Plaza
East Hanover, New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/50 (2006.01) , A61P 39/04 (2006.01) | | Title | Orale formuleringer af deferasirox | | Int. application no. | IB2014059494 | | Int. publication no. | WO2014136079 | | Related patent (certificate) | | | Status | Ændret EP patent ikke valid i DK | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
